Alpha-5 Integrin Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Alpha-5 Integrin General Information

Description

Operator of a preclinical-stage company developing a monoclonal antibody. The company offers a mechanism of action for the treatment of neurodegenerative diseases such as amyotrophic lateral sclerosis and multiple sclerosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 458 Carlton Court
  • San Francisco, CA 94080
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 458 Carlton Court
  • San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alpha-5 Integrin Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alpha-5 Integrin‘s full profile, request access.

Request a free trial

Alpha-5 Integrin Patents

Alpha-5 Integrin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240279345-A1 Alpha 5 beta 1 integrin binding agents and uses thereof Pending 11-May-2021
WO-2022240833-A1 Alpha 5 beta 1 integrin binding agents and uses thereof Inactive 11-May-2021

Alpha-5 Integrin FAQs

  • When was Alpha-5 Integrin founded?

    Alpha-5 Integrin was founded in 2021.

  • Where is Alpha-5 Integrin headquartered?

    Alpha-5 Integrin is headquartered in San Francisco, CA.

  • What industry is Alpha-5 Integrin in?

    Alpha-5 Integrin’s primary industry is Biotechnology.

  • Is Alpha-5 Integrin a private or public company?

    Alpha-5 Integrin is a Private company.

  • What is the current valuation of Alpha-5 Integrin?

    The current valuation of Alpha-5 Integrin is .

  • What is Alpha-5 Integrin’s current revenue?

    The current revenue for Alpha-5 Integrin is .

  • When was Alpha-5 Integrin acquired?

    Alpha-5 Integrin was acquired on 21-Jun-2022.

  • Who acquired Alpha-5 Integrin?

    Alpha-5 Integrin was acquired by Pasithea Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process